Treating T2DM and obesity with bariatric surgery and GLP1 agents

Clifford J. Bailey*

*Corresponding author for this work

Research output: Contribution to journalLetter, comment/opinion or interviewpeer-review


Bariatric surgery often produces remission of hyperglycaemia in patients with coexistent obesity and type 2 diabetes mellitus, but the hyperglycaemia is prone to return years later. A prospective study demonstrates that therapy with a glucagon-like peptide 1 receptor agonist can reinstate normal glycaemic control in many of these patients.
Original languageEnglish
Pages (from-to)504–506
Number of pages3
JournalNature Reviews Endocrinology
Issue number9
Publication statusPublished - 22 Jul 2019


Dive into the research topics of 'Treating T2DM and obesity with bariatric surgery and GLP1 agents'. Together they form a unique fingerprint.

Cite this